Klinicheskaya effektivnost' Dyuspatalina pri patologii biliarnogo trakta

The article presents the results of the study, which evaluated the clinical efficacy of the drug mebeverine (Duspatalin®) in the treatment of diseases of the gallbladder and biliary tract in 68 patients aged 18 to 35 years with a diagnosis of “chronic noncalculous cholecystitis". Both groups of 34 patients received conventional therapy. In addition, first group of patients received drug Duspatalin® 200 mg 2 times a day 20 minutes before meals for 30 days. All patients underwent a complete clinical and laboratory and instrumental evaluation. It was noted that the inclusion of Duspatalin in treatment of patients with biliary tract pathology has a pronounced therapeutic effect in the form of an earlier and full relief of pain and dyspeptic syndromes. Administration of Duspatalin promotes correction of motor-tonic disorders of the gall bladder and sphincter system, and normalization of the physicochemical properties of the cystic and liver bile.

biliary tract pathology, mebeverine, Duspatalin®